Aromatase inhibitors and the incidence of Parkinson disease: A population‐based cohort study-Reference-Cited by-同舟云学术

Aromatase inhibitors and the incidence of Parkinson disease: A population‐based cohort study

Published:2022-04 Issue:12 Volume:128 Page:2339-2347
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Khosrow‐Khavar Farzin¹²^ORCID,Azoulay Laurent¹²³^ORCID,Montastruc Jean‐Louis⁴,Montastruc François⁴,Renoux Christel¹²⁵^ORCID

Affiliation:

1. Department of Epidemiology, Biostatistics, and Occupational Health McGill University Montreal Québec Canada

2. Centre for Clinical Epidemiology Lady Davis Institute Jewish General Hospital Montreal Québec Canada

3. Gerald Bronfman Department of Oncology McGill University Montreal Québec Canada

4. Department of Medical and Clinical Pharmacology Centre of Pharmacovigilance and Pharmacoepidemiology Centre d’Investigation Clinique 1436, Team PEPSS (Pharmacologie en Population Cohortes et Biobanques) Toulouse University Hospital Toulouse France

5. Department of Neurology and Neurosurgery McGill University Montreal Québec Canada

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.34208

Reference47 articles.

1. ER+ metastatic breast cancer: past, present, and a prescription for an apoptosis‐targeted future;Rozeboom B;Am J Cancer Res,2019

2. Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer: ASCO Clinical Practice Guideline Focused Update

3. Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

4. Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tamoxifen in breast cancer and risk of Parkinson's disease: A meta-analysis;The American Journal of the Medical Sciences;2023-11

2. Neither tamoxifen nor aromatase inhibitors increase the risk of Parkinson disease in the UK Biobank cohort;Cancer;2022-04-20